Ticker: AGLE

Company: Aeglea BioTherapeutics, Inc.

Person: Cameron Turtle, director, officer

Transaction date: Aug. 3, 2026

Reporting date: Aug. 5, 2026

Average share price: 95.51367

Sold 15000.0 shares for 1432705.05